Wall Street Zen upgraded shares of Definitive Healthcare (NASDAQ:DH – Free Report) from a hold rating to a buy rating in a report published on Sunday morning. Other analysts also recently issued research reports about the stock. Bank of America reaffirmed an “underperform” rating and issued a $0.70 price target on shares of Definitive Healthcare […]

Wall Street Zen upgraded shares of Tenet Healthcare (NYSE:THC – Free Report) from a hold rating to a buy rating in a research note published on Sunday morning. A number of other research analysts also recently weighed in on the stock. Royal Bank Of Canada reduced their target price on shares of Tenet Healthcare from […]

Tenet Healthcare (NYSE:THC – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Sunday. A number of other research analysts have also issued reports on the stock. KeyCorp decreased their target price on shares of […]

Csquare (NYSE:CSQR – Get Free Report) was upgraded by equities researchers at Wall Street Zen to a “hold” rating in a research note issued to investors on Saturday. Csquare Trading Down 1.3% Shares of CSQR stock opened at $22.48 on Friday. Csquare has a 1-year low of $19.75 and a 1-year high of $23.44. Further […]

NervGen Pharma (NASDAQ:NGEN – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Monday. Several other equities analysts have also weighed in on the company. Weiss Ratings initiated coverage on NervGen Pharma in a report on […]

Definitive Healthcare (NASDAQ:DH – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. DH has been the subject of a number of other reports. Zacks Research raised Definitive Healthcare from a “strong sell” rating to a “hold” rating in […]

Wall Street Zen cut shares of Definitive Healthcare (NASDAQ:DH – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday. Several other equities analysts have also issued reports on the company. Zacks Research upgraded Definitive Healthcare from a “strong sell” rating to a “hold” rating in […]